Nghiên cứu tác dụng cải thiện suy giảm trí nhớ và chống trầm cảm của Hương nhu tía Ocimum sanctum L. trên thực nghiệm

55. Lee, S.-T., K. Chu, J.-Y. Sim, J.-H. Heo, and M. Kim (2008), "Panax ginseng enhances cognitive performance in Alzheimer disease", Alzheimer disease & associated disorders. 22(3), pp. 222-226.

56. Puzzo, D., W. Gulisano, A. Palmeri, and O. Arancio (2015), "Rodent models for Alzheimer’s disease drug discovery", Expert opinion on drug discovery. 10(7), pp. 703-711.

57. Hannan, S.B., N.M. Dräger, T.M. Rasse, A. Voigt, and T.R. Jahn (2016), "Cellular and molecular modifier pathways in tauopathies: the big picture from screening invertebrate models", Journal of neurochemistry. 137(1), pp. 12-25.

58. Newman, M., E. Ebrahimie, and M. Lardelli (2014), "Using the zebrafish model for Alzheimer’s disease research", Frontiers in genetics. 5, pp. 189.

59. Drummond, E. and T. Wisniewski (2017), "Alzheimer’s disease: experimental models and reality", Acta neuropathologica. 133(2), pp. 155-175.

60. Stepanichev, M., N. Lazareva, G. Tukhbatova, S. Salozhin, and N. Gulyaeva (2014), "Transient disturbances in contextual fear memory induced by Aβ (25–

35) in rats are accompanied by cholinergic dysfunction", Behavioural brain research. 259, pp. 152-157.

61. San Tang, K. (2019), "The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers", Life sciences, pp. 116695.

62. Moiseeva, Y.V., M. Onufriev, N. Lazareva, M. Stepanichev, and N. Gulyaeva (2001), "Free radical mechanisms of septo-hippocampal neurodegeneration caused by cholinotoxin AF64A in rats in vivo", Neirokhimiya. 18, pp. 287-289.

63. Sain, H., B. Sharma, A. Jaggi, and N. Singh (2011), "Pharmacological investigations on potential of peroxisome proliferator-activated receptor-gamma agonists in hyperhomocysteinemia-induced vascular dementia in rats", Neuroscience. 192, pp. 322-333.

Có thể bạn quan tâm!

Xem toàn bộ 187 trang tài liệu này.

64. Kamat, P.K., S. Rai, and C. Nath (2013), "Okadaic acid induced neurotoxicity: an emerging tool to study Alzheimer's disease pathology", Neurotoxicology. 37, pp. 163-172.

65. Song, C. and B.E. Leonard (2005), "The olfactory bulbectomised rat as a model of depression", Neuroscience & Biobehavioral Reviews. 29(4-5), pp. 627-647.

66. Hendriksen, H., S.M. Korte, B. Olivier, and R.S. Oosting (2015), "The olfactory bulbectomy model in mice and rat: one story or two tails?", European journal of pharmacology. 753, pp. 105-113.

67. Oba, A., O. Nakagawasai, H. Onogi, W. Nemoto, F. Yaoita, Y. Arai, K. Tan- No, and T. Tadano (2013), "Chronic fluvoxamine treatment changes 5-

HT2A/2C receptor-mediated behavior in olfactory bulbectomized mice", Life sciences. 92(2), pp. 119-124.

68. Almeida, R.F., Y. Nonose, M. Ganzella, S.O. Loureiro, A. Rocha, D.G. Machado, B. Bellaver, F.U. Fontella, D.T. Leffa, and L.F. Pettenuzzo (2021), "Antidepressant-like effects of chronic guanosine in the olfactory bulbectomy mouse model", Frontiers in Psychiatry. 12.

69. Sithisarn, P., P. Rojsanga, S. Jarikasem, K. Tanaka, and K. Matsumoto (2013), "Ameliorative effects of Acanthopanax trifoliatus on cognitive and emotional deficits in olfactory bulbectomized mice: an animal model of depression and cognitive deficits", Evidence-Based Complementary and Alternative Medicine. 2013.

70. Zou, Y.-m., L.-p.L. Da Lu, H.-h. Zhang, and Y.-y. Zhou (2016), "Olfactory dysfunction in Alzheimer’s disease", Neuropsychiatric disease and treatment. 12, pp. 869.

71. Cha, H., S. Kim, and Y. Son (2021), "Associations between cognitive function, depression, and olfactory function in elderly people with dementia in Korea", Frontiers in Aging Neuroscience. 13.

72. Tonacci, A., R.M. Bruno, L. Ghiadoni, L. Pratali, N. Berardi, G. Tognoni, S. Cintoli, L. Volpi, U. Bonuccelli, and R. Sicari (2017), "Olfactory evaluation in mild cognitive impairment: correlation with neurocognitive performance and endothelial function", European Journal of Neuroscience. 45(10), pp. 1279- 1288.

73. Coronas-Sámano, G., W. Portillo, V.B. Campos, G. Medina-Aguirre, R. Paredes, and S. Diaz-Cintra (2014), "Deficits in odor-guided behaviors in the transgenic 3xTg-AD female mouse model of Alzheimer׳ s disease", brain research. 1572, pp. 18-25.

74. Bobkova, N., E. Dana, V. Nesterov, I.Y. Aleksandrova, N. Medvinskaya, A. Samokhin, I. Nesterova, and R. Dana (2004), "Morphofunctional changes in neurons in the temporal cortex of the brain in relation to spatial memory in bulbectomized mice after treatment with mineral ascorbates", Neuroscience and behavioral physiology. 34(7), pp. 671-676.

75. Yamada, M., M. Hayashida, Q. Zhao, N. Shibahara, K. Tanaka, T. Miyata, and

K. Matsumoto (2011), "Ameliorative effects of yokukansan on learning and memory deficits in olfactory bulbectomized mice", Journal of ethnopharmacology. 135(3), pp. 737-746.

76. Le, X.T., H.T.N. Pham, P.T. Do, H. Fujiwara, K. Tanaka, F. Li, T. Van Nguyen, K.M. Nguyen, and K. Matsumoto (2013), "Bacopa monnieri

ameliorates memory deficits in olfactory bulbectomized mice: possible involvement of glutamatergic and cholinergic systems", Neurochemical research. 38(10), pp. 2201-2215.

77. Mizuki, D., Z. Qi, K. Tanaka, H. Fujiwara, T. Ishikawa, Y. Higuchi, and K. Matsumoto (2014), "Butea superba–induced amelioration of cognitive and emotional deficits in olfactory bulbectomized mice and putative mechanisms underlying its actions", Journal of pharmacological sciences. 124(4), pp. 457- 467.

78. Aleksandrova, I.Y., V. Kuvichkin, I. Kashparov, N. Medvinskaya, I. Nesterova,

S. Lunin, A. Samokhin, and N. Bobkova (2004), "Increased level of β-amyloid in the brain of bulbectomized mice", Biochemistry (Moscow). 69(2), pp. 176- 180.

79. Wynn, Z.J. and J.L. Cummings (2004), "Cholinesterase inhibitor therapies and neuropsychiatric manifestations of Alzheimer’s disease", Dementia and geriatric cognitive disorders. 17(1-2), pp. 100-108.

80. Harper, A. (2010), "Mouse models of neurological disorders—a comparison of heritable and acquired traits", Biochimica et Biophysica Acta (BBA)-Molecular Basis of Disease. 1802(10), pp. 785-795.

81. Saiz-Sanchez, D., A. Flores-Cuadrado, I. Ubeda-Banon, C. de la Rosa-Prieto, and A. Martinez-Marcos (2016), "Interneurons in the human olfactory system in Alzheimer's disease", Experimental neurology. 276, pp. 13-21.

82. Djordjevic, J., M. Jones-Gotman, K. De Sousa, and H. Chertkow (2008), "Olfaction in patients with mild cognitive impairment and Alzheimer's disease", Neurobiology of aging. 29(5), pp. 693-706.

83. Ogbo, F.A., S. Mathsyaraja, R.K. Koti, J. Perz, and A. Page (2018), "The burden of depressive disorders in South Asia, 1990–2016: findings from the global burden of disease study", BMC psychiatry. 18(1), pp. 1-11.

84. Association, A.P. (2013), "Diagnostic and statistical manual of mental disorders", BMC Med. 17, pp. 133-137.

85. Czeisler, M.É., R.I. Lane, E. Petrosky, J.F. Wiley, A. Christensen, R. Njai,

M.D. Weaver, R. Robbins, E.R. Facer-Childs, and L.K. Barger (2020), "Mental health, substance use, and suicidal ideation during the COVID-19 pandemic— United States, June 24–30, 2020", Morbidity and Mortality Weekly Report. 69(32), pp. 1049.

86. Wang, Q., M.A. Timberlake II, K. Prall, and Y. Dwivedi (2017), "The recent progress in animal models of depression", Progress in Neuro- Psychopharmacology and Biological Psychiatry. 77, pp. 99-109.

87. Elhwuegi, A.S. (2004), "Central monoamines and their role in major depression", Progress in Neuro-Psychopharmacology and Biological Psychiatry. 28(3), pp. 435-451.

88. Castrén, E. and T. Rantamäki (2010), "The role of BDNF and its receptors in depression and antidepressant drug action: reactivation of developmental plasticity", Developmental neurobiology. 70(5), pp. 289-297.

89. Bremner, J.D., M. Narayan, E.R. Anderson, L.H. Staib, H.L. Miller, and D.S. Charney (2000), "Hippocampal volume reduction in major depression", American Journal of Psychiatry. 157(1), pp. 115-118.

90. Videbech, P. (1997), "MRI findings in patients with affective disorder: a meta‐analysis", Acta Psychiatrica Scandinavica. 96(3), pp. 157-168.

91. Altshuler, L.L., M. Bauer, M.A. Frye, M.J. Gitlin, J. Mintz, M.P. Szuba, K.L. Leight, and P.C. Whybrow (2001), "Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature", American Journal of Psychiatry. 158(10), pp. 1617-1622.

92. Fournier, N.M. and R.S. Duman (2012), "Role of vascular endothelial growth factor in adult hippocampal neurogenesis: implications for the pathophysiology and treatment of depression", Behavioural brain research. 227(2), pp. 440-449.

93. Belmaker, R. and G. Agam (2008), "Major depressive disorder", New England Journal of Medicine. 358(1), pp. 55-68.

94. Tran, P.V., F.P. Bymaster, R.K. McNamara, and W.Z. Potter (2003), "Dual monoamine modulation for improved treatment of major depressive disorder", Journal of clinical psychopharmacology. 23(1), pp. 78-86.

95. Brunton, L.L., B. Chabner, and B.C. Knollmann (2018), Goodman & Gilman's the pharmacological basis of therapeutics. McGraw-Hill Education New York, NY, USA:.

96. Liu, L., C. Liu, Y. Wang, P. Wang, Y. Li, and B. Li (2015), "Herbal medicine for anxiety, depression and insomnia", Current neuropharmacology. 13(4), pp. 481-493.

97. Xu, C., J. Teng, W. Chen, Q. Ge, Z. Yang, C. Yu, Z. Yang, and W. Jia (2010), "20 (S)-protopanaxadiol, an active ginseng metabolite, exhibits strong antidepressant-like effects in animal tests", Progress in Neuro- Psychopharmacology and Biological Psychiatry. 34(8), pp. 1402-1411.

98. Mao, Q., Z. Huang, S. Ip, and C. Che (2008), "Antidepressant‐like effect of ethanol extract from Paeonia lactiflora in mice", Phytotherapy Research: An International Journal Devoted to Pharmacological and Toxicological Evaluation of Natural Product Derivatives. 22(11), pp. 1496-1499.

99. Kim, J.-H., S.Y. Kim, S.-Y. Lee, and C.-G. Jang (2007), "Antidepressant-like effects of Albizzia julibrissin in mice: involvement of the 5-HT1A receptor system", Pharmacology Biochemistry and Behavior. 87(1), pp. 41-47.

100. Mizuki, D., K. Matsumoto, K. Tanaka, X.T. Le, H. Fujiwara, T. Ishikawa, and

Y. Higuchi (2014), "Antidepressant-like effect of Butea superba in mice exposed to chronic mild stress and its possible mechanism of action", Journal of ethnopharmacology. 156, pp. 16-25.

101. Hollis, F. and M. Kabbaj (2014), "Social defeat as an animal model for depression", ILAR journal. 55(2), pp. 221-232.

102. Mumtaz, F., M.I. Khan, M. Zubair, and A.R. Dehpour (2018), "Neurobiology and consequences of social isolation stress in animal model—A comprehensive review", Biomedicine & Pharmacotherapy. 105, pp. 1205-1222.

103. Matsumoto, K., G. Pinna, G. Puia, A. Guidotti, and E. Costa (2005), "Social isolation stress-induced aggression in mice: a model to study the pharmacology of neurosteroidogenesis", Stress. 8(2), pp. 85-93.

104. Nishi, M., N. Horii-Hayashi, T. Sasagawa, and W. Matsunaga (2013), "Effects of early life stress on brain activity: implications from maternal separation model in rodents", General and comparative endocrinology. 181, pp. 306-309.

105. Walther, D.J., J.-U. Peter, S. Bashammakh, H. Hörtnagl, M. Voits, H. Fink, and

M. Bader (2003), "Synthesis of serotonin by a second tryptophan hydroxylase isoform", Science. 299(5603), pp. 76-76.

106. Gutknecht, L., S. Popp, J. Waider, F.M. Sommerlandt, C. Göppner, A. Post, A. Reif, D. van den Hove, T. Strekalova, and A. Schmitt (2015), "Interaction of brain 5-HT synthesis deficiency, chronic stress and sex differentially impact emotional behavior in Tph2 knockout mice", Psychopharmacology. 232(14), pp. 2429-2441.

107. Fukui, M., R.M. Rodriguiz, J. Zhou, S.X. Jiang, L.E. Phillips, M.G. Caron, and

W.C. Wetsel (2007), "Vmat2 heterozygous mutant mice display a depressive- like phenotype", Journal of Neuroscience. 27(39), pp. 10520-10529.

108. Hellweg, R., M. Zueger, K. Fink, H. Hörtnagl, and P. Gass (2007), "Olfactory bulbectomy in mice leads to increased BDNF levels and decreased serotonin turnover in depression-related brain areas", Neurobiology of disease. 25(1), pp. 1-7.

109. Brigitta, B. (2002), "Pathophysiology of depression and mechanisms of treatment", Dialogues in clinical neuroscience. 4(1), pp. 7.

110. Katz, R.J. (1982), "Animal model of depression: pharmacological sensitivity of a hedonic deficit", Pharmacology Biochemistry and Behavior. 16(6), pp. 965- 968.

111. Willner, P., A. Towell, D. Sampson, S. Sophokleous, and R.a. Muscat (1987), "Reduction of sucrose preference by chronic unpredictable mild stress, and its restoration by a tricyclic antidepressant", Psychopharmacology. 93(3), pp. 358- 364.

112. Solomon, M.B., A.R. Furay, K. Jones, A.E. Packard, B.A. Packard, A.C. Wulsin, and J.P. Herman (2012), "Deletion of forebrain glucocorticoid receptors impairs neuroendocrine stress responses and induces depression-like behavior in males but not females", Neuroscience. 203, pp. 135-143.

113. Yu, O.-C., B. Jung, H. Go, M. Park, and I.-H. Ha (2020), "Association between dementia and depression: a retrospective study using the Korean National Health Insurance Service-National Sample Cohort database", BMJ open. 10(10), pp. e034924.

114. Zubenko, G.S., W.N. Zubenko, S. McPherson, E. Spoor, D.B. Marin, M.R. Farlow, G.E. Smith, Y.E. Geda, J.L. Cummings, and R.C. Petersen (2003), "A collaborative study of the emergence and clinical features of the major depressive syndrome of Alzheimer’s disease", American Journal of Psychiatry. 160(5), pp. 857-866.

115. Steffens, D.C. and G. Potter (2008), "Geriatric depression and cognitive impairment", Psychological medicine. 38(2), pp. 163-175.

116. Rapp, M.A., M. Schnaider-Beeri, M. Wysocki, E. Guerrero-Berroa, H.T. Grossman, A. Heinz, and V. Haroutunian (2011), "Cognitive decline in patients with dementia as a function of depression", The American Journal of Geriatric Psychiatry. 19(4), pp. 357-363.

117. Diniz, B.S., M.A. Butters, S.M. Albert, M.A. Dew, and C.F. Reynolds (2013), "Late-life depression and risk of vascular dementia and Alzheimer's disease: systematic review and meta-analysis of community-based cohort studies", The British Journal of Psychiatry. 202(5), pp. 329-335.

118. Alexopoulos, G.S. (2003), "Vascular disease, depression, and dementia".

119. Sierksma, A.S., D.L. van den Hove, H.W. Steinbusch, and J. Prickaerts (2010), "Major depression, cognitive dysfunction and Alzheimer's disease: is there a link?", European Journal of Pharmacology. 626(1), pp. 72-82.

120. Green, K.N., L.M. Billings, B. Roozendaal, J.L. McGaugh, and F.M. LaFerla (2006), "Glucocorticoids increase amyloid-β and tau pathology in a mouse

model of Alzheimer’s disease", Journal of Neuroscience. 26(35), pp. 9047- 9056.

121. Caraci, F., A. Copani, F. Nicoletti, and F. Drago (2010), "Depression and Alzheimer's disease: neurobiological links and common pharmacological targets", European journal of pharmacology. 626(1), pp. 64-71.

122. Berger, T., H. Lee, A.H. Young, D. Aarsland, and S. Thuret (2020), "Adult hippocampal neurogenesis in major depressive disorder and Alzheimer’s disease", Trends in molecular medicine. 26(9), pp. 803-818.

123. Toni, N. and A.F. Schinder (2016), "Maturation and functional integration of new granule cells into the adult hippocampus", Cold Spring Harbor perspectives in biology. 8(1), pp. a018903.

124. Moreno-Jiménez, E.P., M. Flor-García, J. Terreros-Roncal, A. Rábano, F. Cafini, N. Pallas-Bazarra, J. Ávila, and M. Llorens-Martín (2019), "Adult hippocampal neurogenesis is abundant in neurologically healthy subjects and drops sharply in patients with Alzheimer’s disease", Nature medicine. 25(4), pp. 554-560.

125. Gatt, A., A. Ekonomou, A. Somani, S. Thuret, D. Howlett, A. Corbett, M. Johnson, E. Perry, J. Attems, and P. Francis (2017), "Importance of proactive treatment of depression in Lewy body dementias: the impact on hippocampal neurogenesis and cognition in a post-mortem study", Dementia and Geriatric Cognitive Disorders. 44(5-6), pp. 283-293.

126. Pelton, G.H., O.L. Harper, M.H. Tabert, H.A. Sackeim, N. Scarmeas, S.P. Roose, and D. Devanand (2008), "Randomized double‐blind placebo‐controlled donepezil augmentation in antidepressant‐treated elderly patients with depression and cognitive impairment: a pilot study", International Journal of Geriatric Psychiatry: A journal of the psychiatry of late life and allied sciences. 23(7), pp. 670-676.

127. Võ Văn Chi (2004), "Từ điển thực vật thông dụng". 2, tr. 1808-1810.

128. Viện Dược liệu (2006), "Cây thuốc và động vật làm thuốc ở Việt Nam". 1, tr. 1027 - 1029.

129. Pattanayak, P., P. Behera, D. Das, and S.K. Panda (2010), "Ocimum sanctum Linn. A reservoir plant for therapeutic applications: An overview", Pharmacognosy reviews. 4(7), pp. 95.

130. Bộ Y tế (2017), "Dược điển Việt Nam V".

131. Gupta, S., J. Prakash, and S. Srivastava (2002), "Validation of traditional claim of Tulsi, Ocimum sanctum Linn. as a medicinal plant", Indian J Exp Biol. 40(7), pp. 9.

132. Vrinda, B. and P.U. Devi (2001), "Radiation protection of human lymphocyte chromosomes in vitro by orientin and vicenin", Mutation Research/Genetic Toxicology and Environmental Mutagenesis. 498(1-2), pp. 39-46.

133. Endo, A., M. Matsumoto, T. Inada, A. Yamamoto, K.I. Nakayama, N. Kitamura, and M. Komada (2009), "Nucleolar structure and function are regulated by the deubiquitylating enzyme USP36", J Cell Sci. 122(5), pp. 678- 686.

134. Silva, M.G., I. Vieira, F. Mendes, I. Albuquerque, R. Dos Santos, F. Silva, and

S. Morais (2008), "Variation of ursolic acid content in eight Ocimum species from northeastern Brazil", Molecules. 13(10), pp. 2482-2487.

135. Lê Đình Sáng (2010), "Bách khoa Y học".

136. Vats, V., S. Yadav, and J. Grover (2004), "Ethanolic extract of Ocimum sanctum leaves partially attenuates streptozotocin-induced alterations in glycogen content and carbohydrate metabolism in rats", Journal of ethnopharmacology. 90(1), pp. 155-160.

137. Giridharan, V.V., R.A. Thandavarayan, V. Mani, T. Ashok Dundapa, K. Watanabe, and T. Konishi (2011), "Ocimum sanctum Linn. leaf extracts inhibit acetylcholinesterase and improve cognition in rats with experimentally induced dementia", Journal of medicinal food. 14(9), pp. 912-919.

138. Bathala, L.R., C.V. Rao, S. Manjunath, S. Vinuta, and R. Vemulapalli (2012), "Efficacy of Ocimum sanctum for relieving stress: a preclinical study", J Contemp Dent Pract. 13(6), pp. 782-786.

139. Chatterjee, M., P. Verma, R. Maurya, and G. Palit (2011), "Evaluation of ethanol leaf extract of Ocimum sanctum in experimental models of anxiety and depression", Pharmaceutical biology. 49(5), pp. 477-483.

140. Sembulingam, K., P. Sembulingam, and A. Namasivayam (2005), "Effect of Ocimum sanctum Linn on the changes in central cholinergic system induced by acute noise stress", Journal of ethnopharmacology. 96(3), pp. 477-482.

141. Gupta, P., D.K. Yadav, K.B. Siripurapu, G. Palit, and R. Maurya (2007), "Constituents of Ocimum sanctum with antistress activity", Journal of natural products. 70(9), pp. 1410-1416.

142. Ahmad, A., N. Rasheed, K. Chand, R. Maurya, N. Banu, and G. Palit (2012), "Restraint stress-induced central monoaminergic & oxidative changes in rats & their prevention by novel Ocimum sanctum compounds", The Indian journal of medical research. 135(4), pp. 548.

143. Machado, D., V. Neis, G. Balen, A. Colla, M. Cunha, J. Dalmarco, M. Pizzolatti, R. Prediger, and A. Rodrigues (2012), "Antidepressant-like effect of